• search
Viral Vectors Viral Vectors

Viral Vectors

We offer a diverse range of services in the area of viral vector generation for Cell and Gene Therapy (CGT).

The most effective method of gene transfer for modifying specific cell types or tissues is viral vector, which can be used for expressing therapeutic genes.

Speak to our experts

Lentiviral vector system to develop producer cell lines (for difficult-to-express proteins)

  • Lentiviral system is useful when other transient expression systems viz. Expi / TranslT pro/ PEI yield low or negligible expression of target protein.
  • 10 to 100-fold higher titer as compared to transient expression
  • High stability of clones/ pool without selection pressure
  • Rapid selection resulting in faster TAT (4 - 6 weeks)
  • Cost effective

Lentiviral vector system to develop Reporter cell lines (GFP / RFP/ F-luc expressing cell lines)

  • Reporter cell lines are tools for in vitro / in vivo screening and efficacy evaluation
  • These cell lines (RFP/F-Luc) enable non-invasive detection and quantitation of subcutaneous, orthotopic, and metastatic xenografts in preclinical mouse models using bioluminescent imaging
  • Experience in generating orthotopic reporter cell lines for breast, prostate, melanoma, glioblastoma, colorectal, lung, and B-cell malignancies
  • In-house modified lentiviral vector system to develop reporter cell lines
  • Timelines: 12 - 16 weeks

Lentiviral vector system for generating Knock-down (KD) cell lines (SiRNA/ShRNA)

Knock-down cell lines are tools for in vitro / in vivo screening, binding studies, and efficacy evaluation and serve as disease models:

  • Single, double, or multiple gene knock-down of primary and established cell lines
  • Timelines: 12 - 16 weeks

Why Aurigene Viral Vectors Services?

Customized vector construction

State-of-the-art facilities

Regulatory audits and compliance to statutory norms

Team of scientists with extensive experience in viral vector generation

Virtual Tour

 

Connect with our scientific experts for your drug discovery, development, and manufacturing needs

We understand that clear communication is essential to successful collaborations, and that's why we have a dedicated team that is always ready to help you. Whether you have questions about our services, want to discuss a potential partnership, or simply want to learn more about our company, we're here to help.

Our team of experts is dedicated to providing personalised solutions tailored to your unique needs. So, please don't hesitate to reach out to us. We look forward to hearing from you and helping you achieve your business goals.

Country

section

CAPTCHA
この質問はあなたが人間の訪問者であるかどうかをテストし、自動化されたスパム送信を防ぐためのものです。

rightCaptcha

寡核苷酸作为一种新型治疗方式

JULY 02, 2021

寡核苷酸作为一种新型治疗方式

寡核苷酸作为一种治疗类别是发现用于治疗人类疾病的新的重要治疗剂的革命性方法。基于 RNA 的干预有时适用于其他方式不起作用的情况。例如,它可能有助于治疗先天性新陈代谢错误、遗传疾病和罕见病 寡核苷酸疗法是将化学修饰的寡核苷酸用于治疗目的。寡核苷�...

Read More

Methoxy Polyethylene Glycol (m-PEGs)

Aurigene Pharmaceutical Services is a leader in the synthesis of activated MethoxyPolyethyleneGlycol(m-PEGs), With a comprehensive product range and customized services. ...

Read More

Base mediated spirocyclization of quinazoline: one-step synthesis of spiro-isoindolinone dihydroquinazolinones

2020

A novel approach for the spiro-isoindolinone dihydroquinazolinones has been demonstrated from 2- aminobenzamide and 2-cyanomethyl benzoate in the presence of KHMDS as a base to get moderate yields. The reaction has been screened in various bases followed by solvents and a gram scale reaction has also been executed under the given conditions. Based on the controll...

Read More
View All
×

You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.

If you wish to continue to this external website, click Proceed.

ProceedBack